Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Multi-omics industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Products & services trends
2.1.4 Type trends
2.1.5 Platform trends
2.1.6 Application trends
2.1.7 End-use trends
Chapter 3 Multi-omics Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in omics technologies
3.2.1.2 Increasing applications in personalized medicine
3.2.1.3 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments and data storage
3.2.2.2 Complex regulatory requirements and standardization issues
3.3 Growth potential analysis
3.3.1 By products & services
3.3.2 By type
3.3.3 By platform
3.3.4 By application
3.3.5 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Multi-omics Market Estimates and Forecast, By Products & Services, 2018-2032 (USD Million)
5.1 Key trends, by products & services
5.2 Products
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Software
5.3 Services
Chapter 6 Multi-omics Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
6.1 Key trends, by type
6.2 Single-cell multi-omics
6.3 Bulk multi-omics
Chapter 7 Multi-omics Market Estimates and Forecast, By Platform, 2018-2032 (USD Million)
7.1 Key trends, by platform
7.2 Genomics
7.3 Proteomics
7.4 Metabolomics
7.5 Transcriptomics
7.6 Integrated omics platforms
Chapter 8 Multi-omics Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
8.1 Key trends, by application
8.2 Cell biology
8.3 Oncology
8.4 Neurology
8.5 Immunology
8.6 Other applications
Chapter 9 Multi-omics Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
9.1 Key trends, by end-use
9.2 Academic and research organizations
9.3 Pharmaceutical & biotechnology companies
9.4 Hospital and diagnostic laboratories
9.5 Other end-users
Chapter 10 Multi-omics Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Becton, Dickinson and Company
11.2 Thermo Fisher Scientific Inc.
11.3 Illumina, Inc
11.4 Danaher
11.5 PerkinElmer Inc.
11.6 Shimadzu Corporation
11.7 Bruker
11.8 QIAGEN
11.9 Agilent Technologies, Inc.
11.10 BGI
11.11 10x Genomics
11.12 CYTENA GmbH
